Symbicort Turbuhaler 160 mikrograma/4,5 mikrograma po inhalaciji, prašak inhalata
| Name | Symbicort Turbuhaler 160 mikrograma/4,5 mikrograma po inhalaciji, prašak inhalata |
|---|---|
| Marketing Authorisation Number | HR-H-203679076 |
| Active Substance | budezonid formoterolfumarat dihidrat |
| Composition | jedna inhalacijska doza sadrži 160 mikrograma budesonida i 4,5 mikrograma formoterolfumarat dihidrata |
| Pharmaceutical Form | prašak inhalata |
| Manufacturer | AstraZeneca AB, Sodertalje, Švedska |
| Marketing Authorisation Holder | AstraZeneca d.o.o., Ulica Vjekoslava Heinzela 70, Zagreb, Hrvatska |
| Marketing Authorisation Date | 29.11.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/18-02/351 |
| Registration Number | 381-12-01/38-19-02 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R03AK07 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
| Additional information | video instructions for use |
